Valuation (45%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.47 | N/A |
| PEG Ratio (TTM) | 5.98 | N/A |
| P/S Ratio (TTM) | 1.56 | N/A |
| P/B Ratio (TTM) | 3.65 | N/A |
| P/FCF Ratio (TTM) | 114.60 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.03 | N/A |
| Price to 5YR AVG FCF Ratio | -56.39 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.26% | N/A |
| ROE (TTM) | 25.68% | N/A |
| Net Profit Margin (TTM) | 10.09% | N/A |
| ROIC 5YR AVG | 10.51% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.48% | 73.31% | 55.29% |
| Revenue | 1.88% | 2.21% | 11.71% |
| Net Income | 8.48% | 75.95% | 56.06% |
| Cash Flow | 6.12% | 10.53% | 14.65% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.22 | N/A |
| Quick Ratio (TTM) | 1.22 | N/A |
| D/E Ratio (TTM) | 2.83 | N/A |
| Interest Coverage (TTM) | 3.01 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.33 | N/A |
| LTL to 5YR AVG FCF | -46.30 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.09% | N/A |